We examine how CMS F841 and new OIG oversight raise expectations for nursing home medical directors, demanding visible engagement, better policies, and data-informed leadership. We share field lessons on antipsychotics, facility assessment, and building dashboards that support real accountability.
• CMS shifts from F501 to F841 and clarifies medical director duties
• OIG focus on engagement, visit frequency, and compensation integrity
• Risks of absent or passive medical directors in daily care
• Antipsychotics oversight, diagnostic accuracy, and documentation alignment
• Hands-on leadership beyond QAPI with nursing and administration
• Facility assessment that reflects the real resident mix and needs
• Data and AI dashboards to drive timely, targeted action
• Contracts, coverage, and accountability that sustain engagement
We trace how OIG’s guidance elevates patient safety and quality from ideals to daily compliance work, and share lessons from Corporate Integrity Agreements that separate paper programs from living systems. Practical tools, clear dashboards, and a culture of “why” turn metrics into safer resident care.…
